Skip to main content

Table 1 Summary of the patient’s CSF and serum parameters. Samples collected on the day of the acceptance and during follow-up visits

From: Subacute transverse myelitis with optic symptoms in neuroborreliosis: a case report

Date of samples collection

Admission

After Antibiotic Treatment

1 - Month Follow - up

6 - Month Follow - up

Reference Values

CSF

CSF cell count/mm3(%lymphocytes)

323 (70%)

15 (70%)

5 (70%)

4 (70%)

 

Protein level [g/L]

2.15

0.68

0.58

0.43

0,15 - 0,45

Albumin [mg/l]

1374

408

299

–

0.0–350.0

BbIgM [AU/mL]a

105.7

75,750

63.4

34.068

<  2.5

BbIgG [AU/mL]a

238.8

240

74.43

26.64

< 10

Bb- specific AI

> 1.5

> 1.5

> 1.5

> 1.5

0.0–1.3 - negative

> 1.5 - positive

Serum

Serum IgG against VIsE/C6 peptide [RU/ml]b

1462

472

–

130.99

<  20

BbIgG [AU/mL]a

154.8

200.7

71.3

53.00

<  4.5

BbIgM [AU/mL]a

98.62

87.96

80.31

52.32

<  18

Negative diagnostic tests performed

Serum AQP-4 IgG

- VDRL

- HCV Ab

 HIV Ag/Ab

- HSV 1/2 IgM

- HBV Ab

 CMV IgM

- EBV IgM

- ANA

  1. a Tests performed using ELISA method (Euroimmun,Wroclaw, Poland, Cat. EI 2132–9601-2 G)
  2. b Approximately 4-fold or higher decrease in VIsE IgG titre during 6 month period after antibiotic treatment indicating the effectiveness of treatment (Euroimmun,Wroclaw, Poland, Cat. EI 2132–9601-2 G). Ab antibody, Ag antigen, AI Intrathecal Specific Anitbody Index, Bb Borellia burgderoferi, CMV Cytomegalovirus, HSV Herpes Simplex Virus, HBV/HVC Hepatitis B/C virus, EBV Epstein - Barr Virus, HIV Human Immunodeficency Virus, VDRL Veneral Research Disease Laboratory Test, AQP - 4 Aquaporin 4, ANA Antinuclear Antibodies